Meredith Manning
Partner
Washington, D.C.
Denver
Phone
+1 202 637 6585 (Washington, D.C.)
+1 202 637 6585 (Washington, D.C.)
+1 303 899 7385 (Denver)
+1 303 899 7385 (Denver)
Fax
+1 202 637 5910 (Washington, D.C.)
+1 202 637 5910 (Washington, D.C.)
+1 303 899 7333 (Denver)
+1 303 899 7333 (Denver)
Practice Group
Regulatory
For over 20 years, Meredith Manning has counseled clients on emerging legal issues of pharmaceutical regulatory law. Her goal is to help companies get drugs approved and help them succeed. Her first client was the FDA, and she now advises companies of all sizes on cutting-edge regulatory compliance issues. Clients value her "client service-oriented nature" and "the practicality of her advice."
Meredith's focus extends from clinical trials to good manufacturing practices, drug safety, and advertising and promotion. She watches emerging issues over time, applies her insights into regulators' thinking, and works with clients to build practical approaches to critical business processes and strategies.
Meredith works on major investigations into off-label promotion, client responses to FDA warning and untitled letters, and competitor complaints. She also guides client decisions about drug advertising, drug sampling, patient support programs, and comprehensive pharmaceutical compliance programs. In this role, she has helped develop business strategies for several of the largest drug launches in recent years.
She began her legal career in the Office of Chief Counsel at the FDA and moved to the DOJ as an Assistant United States Attorney for the District of Columbia. She's been at Hogan Lovells since 2002, has served as the co-director of the firm's Pharmaceutical Practice Group, and currently sits on the steering committee for its Life Sciences industry team.
Meredith is nationally ranked in Chambers USA, Legal 500, and LMG Life Sciences. In 2012, the American Health Lawyers Associate named her a Pro Bono Champion for her work on an HIV and AIDS project in D.C. She also serves on the Board of Trustees of the Emma Willard School in Troy, New York.
"Meredith Manning focuses her energies on both routine and on extraordinary client needs for drug companies. This dual approach serves her clients well, as it prevents emergent issues from growing. On-going service to her clients includes counseling on day-to-day compliance problems such as clinical trials, [and] advertising and promotion..."
"Meredith Manning focuses her energies on both routine and on extraordinary client needs for drug companies. This dual approach serves her clients well, as it prevents emergent issues from growing. On-going service to her clients includes counseling on day-to-day compliance problems such as clinical trials, [and] advertising and promotion..."
Areas of Focus
Representative Experience
Latest thinking and events
Hogan Lovells Publications
In The Midnight Hour: FDA Issues 2 Draft Guidances and a First Amendment Memorandum on the Cusp of a New Administration
Pharmaceutical and Biotechnology AlertHogan Lovells Publications
Short-Fuse Compliance Deadline for Expanded Access Provision in 21st Century Cures Act
Focus on RegulationHogan Lovells Publications
Much to Metabolize: The 21st Century Cures Act Introduces Numerous Changes to FDA’s Drug Regulatory Framework to Spur Development of New Treatments
Pharmaceutical and Biotechnology AlertHogan Lovells Publications
FDA Got An Earful: FDA’s Part 15 Public Hearing on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products
Pharmaceutical and Medical Device AlertHogan Lovells Publications
Congress Enacts Comprehensive Addiction and Recovery Act of 2016
Pharmaceutical AlertView More
